Kalamazoo, MI, United States of America

David John Anderson

This inventor holds 18 USPTO granted patents, primarily in Antiviral Compounds. Top assignees: Pharmacia & Upjohn Company, The Upjohn Co., Pfizer Corporation. Active years: 1976-2005.

IDiyas Innovation Intelligence. (2026). Inventor Profile: David John Anderson. Retrieved from https://idiyas.com/inventor/david-john-anderson

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 83.3

Average Co-Inventor Count = 2.7

ph-index = 9

Forward Citations = 193(Granted Patents)


Location History:

  • Glendale, CA (US) (1976)
  • Portage, MI (US) (1989)
  • Kalamazoo, MI (US) (1981 - 2005)

Company Filing History:


Years Active: 1976-2005

Loading Chart...
Areas of Expertise:
Antiviral Compounds
Heterocycle Carboxamides
Oxazolidinones
Phosphonoacetic Esters
Immunosuppressive Agents
Thiadiazolyl Agents
Benzothiazoles
Benzimidazoles
Benzoxazoles
Retroviral Infections
Pyranone Compounds
Dithiocarbanilic Acids
18 patents (USPTO):Explore Patents

Title: David John Anderson: Innovator in Antiviral Compounds

Introduction

David John Anderson is a notable inventor based in Kalamazoo, MI (US). He has made significant contributions to the field of antiviral compounds, holding a total of 18 patents. His work focuses on developing innovative solutions for preventing and treating viral infections.

Latest Patents

Among his latest patents, Anderson has developed compounds that provide effective antiviral properties. One of his inventions includes a compound of formula I, which is designed to prevent or treat herpesvirus infections. This invention also encompasses processes and intermediates useful for preparing such compounds or their pharmaceutically acceptable salts. Another significant patent involves heterocycle carboxamides as antiviral agents, showcasing his commitment to advancing antiviral research.

Career Highlights

Throughout his career, David John Anderson has worked with prominent companies in the pharmaceutical industry. Notably, he has been associated with Pharmacia & Upjohn Company and The Upjohn Company. His experience in these organizations has contributed to his expertise in developing antiviral agents.

Collaborations

Anderson has collaborated with several professionals in his field, including Steven Ronald Turner and Karen Rene Romines. These collaborations have likely enhanced his research and development efforts in antiviral compounds.

Conclusion

David John Anderson's innovative work in antiviral compounds has positioned him as a key figure in the field. His numerous patents reflect his dedication to improving health outcomes through scientific advancements.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…